JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

Начало・Списък с акции・VolitionRX Ltd

VolitionRX Ltd

Затворен

0.6 -1.64

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

0.59

Максимум

0.62

Ключови измерители
By Trading Economics
Приходи	381K -5.5M
Продажби	55K 246K
EPS	-0.06
Марж на печалбата	-2,222.792
Служители	82
EBITDA	369K -5.1M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+222.58% upside

Дивиденти
By Dow Jones
Следващи печалби	14.08.2025 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	15M 65M
Предишно отваряне	2.24
Предишно затваряне	0.6

VolitionRX Ltd Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

11.08.2025 г., 17:49 ч. UTC

Значими двигатели на пазара

180 Life Sciences Stock Jumps on $156 Million Notes Sale

11.08.2025 г., 17:18 ч. UTC

Значими двигатели на пазара

Tiziana Life Sciences Rises After FDA Approves IND for Foralumab Trial

11.08.2025 г., 16:25 ч. UTC

Печалби

Correction to Constellation Software 2Q Revenue Rises, Profit Shrinks Article on Aug. 8

11.08.2025 г., 23:50 ч. UTC

Пазарно говорене

Nikkei May Rise as Yen Weakens -- Market Talk

11.08.2025 г., 23:42 ч. UTC

Пазарно говорене

Global Energy Roundup: Market Talk

11.08.2025 г., 23:42 ч. UTC

Пазарно говорене

Woodside's Share Price Implies Lofty Oil Price -- Market Talk

11.08.2025 г., 23:36 ч. UTC

Пазарно говорене

Gold Edges Higher on Likely Technical Recovery -- Market Talk

11.08.2025 г., 23:32 ч. UTC

Пазарно говорене

Argosy's New Bull Sees Sentiment Toward REITs Improving -- Market Talk

11.08.2025 г., 23:02 ч. UTC

Пазарно говорене

RBA Set to Lower OCR With New Forecasts in Focus -- Market Talk

11.08.2025 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

11.08.2025 г., 20:37 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Bakkt Holdings: Andy Main Will Step Dn as Co-CEO and Director, Effective Aug 11, and Akshay Naheta Will Assume Role of CEO >BKKT

11.08.2025 г., 20:37 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Bakkt Holdings 2Q Rev $577.9M >BKKT

11.08.2025 г., 20:37 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Bakkt Holdings: In Upcoming Qtr, Will Conduct Comprehensive Review of Cost Structure to Ensure We Are Optimized, Driving Synergies Across Business, and Accelerating Path to Profitability >BKKT

11.08.2025 г., 20:22 ч. UTC

Печалби

Exodus Movement: Assets 2,058 Units of Bitcoin Valued at $220.5M, 2,729 Units of Ether Valued at $6.8M, $58.1M in Cash and Cash Equivalents, USD Coin, Treasury Bills as of June 30 >EXOD

11.08.2025 г., 20:22 ч. UTC

Печалби

Exodus Movement: Monthly Active Users 1.5M at End 2Q, Unchanged From 1.5M as of June 30, 2024 >EXOD

11.08.2025 г., 20:22 ч. UTC

Печалби

Exodus Movement: Processed Volume $1.38B in 2Q Dn 37% From 1Q, Bitcoin, Tether (TRX Network), Tether (ETH Network), USDC, SOL Top Assets Traded in 2Q >EXOD

11.08.2025 г., 20:22 ч. UTC

Печалби

Exodus Movement: Digital Assets and Liquid Assets $291.2M >EXOD

11.08.2025 г., 20:22 ч. UTC

Печалби

Exodus Movement 2Q Rev $25.8M >EXOD

11.08.2025 г., 20:14 ч. UTC

Пазарно говорене

Canada Dollar Faces Near-Term Weakness on Trade Row, September Rate-Cut Chatter -- Market Talk

11.08.2025 г., 19:12 ч. UTC

Пазарно говорене

Crude-Oil Futures Edge Up in Rangebound Trade -- Market Talk

11.08.2025 г., 18:56 ч. UTC

Пазарно говорене

U.S. Natural-Gas Futures Fall on Forecast Loss of Late August Heat -- Market Talk

11.08.2025 г., 18:31 ч. UTC

Пазарно говорене

Mining Halt Could Lift Lithium Prices in Near Term -- Market Talk

11.08.2025 г., 17:43 ч. UTC

Пазарно говорене

Freeport-McMoRan Can Push Up Prices, Profits With Copper Tariff Protection -- Market Talk

11.08.2025 г., 17:28 ч. UTC

Пазарно говорене

Crossborder Trade Tensions Accelerate Softness in Canada Rents -- Market Talk

11.08.2025 г., 17:16 ч. UTC

Пазарно говорене

Commodity Longs Fall to 11-Month Low -- Market Talk

11.08.2025 г., 16:42 ч. UTC

Придобивния, сливания и поглъщания

Adobe Stock Gets a Downgrade. 'AI Is Eating Software,' Analyst Says. -- Barrons.com

11.08.2025 г., 16:27 ч. UTC

Придобивния, сливания и поглъщания

BBVA Says Sabadell Offer Remains in Effect

11.08.2025 г., 16:26 ч. UTC

Придобивния, сливания и поглъщания

BBVA Previously Said It Won't Withdraw Offer to Buy Sabadell

11.08.2025 г., 16:25 ч. UTC

Придобивния, сливания и поглъщания

Banco de Sabadell Announced TSB Sale on July 1

11.08.2025 г., 16:25 ч. UTC

Придобивния, сливания и поглъщания

Banco de Sabadell Shareholders Approved TSB Unit Sale on Aug 6

Сравнение с други в отрасъла

Ценова промяна

VolitionRX Ltd Прогноза

Ценова цел

By TipRanks

222.58% нагоре

12-месечна прогноза

Среден 2 USD 222.58%

Висок 3 USD

Нисък 0.5 USD

Според 4 анализатори от Wall Street, предложили 12-месечна ценова цел за VolitionRX Ltd през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

4 ratings

Купи

Задържане

Продай

Според 4 анализатори, дали борсови рейтинги на VolitionRX Ltd през последните 3 месеца.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно VolitionRX Ltd

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes. VolitionRx Limited is based in Henderson, Nevada.